Skip to main content
Beat Cancer EU Website Logo
IGHG Guideline on Hypothalamic-Pituitary Dysfunction
Quality of LifeAllGuidelines

IGHG Guideline on Hypothalamic-Pituitary Dysfunction

Recommendations for surveillance for hypothalamic-pituitary dysfunction in survivors

Year:2021

Childhood, adolescent and young adult cancer survivors may develop treatment-induced hypothalamic-pituitary dysfunction. Because of this risk, at-risk survivors may benefit from surveillance of hypothalamic-pituitary dysfunction surveillance. This guideline describes the groups at risk and the surveillance recommended for this group

Discussion & Questions

Note: Comments are for discussion and clarification only. For medical advice, please consult with a healthcare professional.

Leave a Comment

Minimum 10 characters, maximum 2000 characters

No comments yet

Be the first to share your thoughts!